Proactive Investors - Run By Investors For Investors

Ceapro looks to pivot to become a nutraceutical & biopharma from a contract manufacturer

Ceapro Inc (CVE:CZO) (OTCMKTS: CRPOF) CEO Giles Gagnon  sat down with Proactive Investors at the 11th Annual Biotech Showcase in San Francisco.

The Canadian biotechnology company is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.

 
View full CZO profile View Profile

Ceapro Inc. Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use